CompletedNCT00221975
Divalproex with lamotrigine for rapid-cycling bipolarity
About this title
Read the official source — NCT00221975Medication studyAges 16–65United States
Understand this study
Who was this study for?
Listed age limits: 16 years to 65 years.
- Listed locations
- ClevelandSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateJuly 2002
- Recruitment status
- Completed
- Enrollment listed in the registry
- 98
- Sponsor
- University Hospitals Cleveland Medical Center
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States
- Age range
- From 16 Years to 65 Years
- Official registry ID
- NCT00221975
- Official title
Show the full official title
Combination Therapy in Dual Diagnosis Rapid Cycling Bipolar Disorder
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Cleveland
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University Hospitals Cleveland Medical Center, a university.
Did this study involve medication?
Yes. The study involved medication, including Divalproex, lamotrigine and lithium.
Who was this study for?
Listed age limits: 16 years to 65 years.
